InsiderTrades

Form 4 for FLNA FILANA THERAPEUTICS, INC.

Accepted 2024-04-17 00:00:00 ET · period of report 2024-04-17 · accession 0001437749-24-012331 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-04-17 2024-04-17 FLNA Schoen Eric CFO M - OptEx $22.00 +1,500 21.3K +8% +$33.0K
D 2024-04-17 2024-01-03 FLNA Schoen Eric CFO A - Grant $0.00 +7,920 7,920 New $0
D 2024-04-17 2024-04-17 FLNA Schoen Eric CFO M - OptEx $0.00 -1,000 6,920 -13% $0
DI 2024-04-17 2024-01-03 FLNA Schoen Eric CFO A - Grant $0.00 +800 800 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-04-17 M A 1,500 $22.00 21,300 D — — (F1) Form 4 represents exercise for cash of common stock warrants received on January 3, 2024. Holder received one and one-half shares of common stock for each common stock warrant exercised.
2 Derivative Common Stock Warrant 2024-01-03 A A 7,920 $0.00 7,920 D By limited liability corporation $33.00 · 2024-01-03 to 2024-05-07 11,880 Common Stock (F2) Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.
3 Derivative Common Stock Warrant 2024-04-17 M D 1,000 $0.00 6,920 D $33.00 · 2024-01-03 to 2024-05-07 1,500 Common Stock
4 Derivative Common Stock Warrant 2024-01-03 A A 800 $0.00 800 I $33.00 · 2024-01-03 to 2024-05-07 1,200 Common Stock (F2) Represents warrants that were originally issued on January 3, 2024 as a pro-rata distribution to all holders of common shares. Each warrant entitles the holder to purchase one and one-half common shares at an exercise price of $33.00 per warrant. This distribution was exempt from immediate reporting under Section 16.